Kannan Vishwanath, VC & MD at Aanjaneya Lifecare, says it was a good first quarter for the company with sales growing to Rs 100 crore due to much faster growth in formulation than bulk drugs. Aanjaneya Lifecare’s net profit rose by 57.62 per cent year-on-year to Rs 11.27 crore for the quarter ended June 30, 2011.
